Alzheimer’s Therapeutics Market Shoots USD 14,856.3 Mn by 2028 with Pfizer, Inc., Merck & Co. Inc., Novartis AG, Eisai Co. Ltd., H. Lundbeck A/S, AC Immune, TauRx Pharmaceuticals Ltd., Actavis plc., Forest Laboratories, Teva Pharmaceuticals Industries Ltd.